China Rural Hypertension Control Project 2014

Withdrawn

• Conditions: Hypertension

• Registration Number: NCT02150382
• Lead Sponsor: First Hospital of China Medical University

Brief Summary

China Rural Hypertension Control (CRHC) Project is a cluster randomized trial aims to test the effectiveness of a standardized protocol-based treatment program on hypertension control in rural China.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02
• Status Verified: 2014-05
• Study First Submitted: 2014-05-26
• Study First Submitted QC: 2014-05-26
• Study First Posted: 2014-05-29
• Primary Completion: 2016-07
• Study Completion: 2016-10
• Last Update Submitted: 2022-07-26
• Last Update Posted: 2022-07-29

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Man and women aged 40 years or older.
• Mean systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg; and/or use of antihypertensive medications.Mean blood pressure is based on three measurements at two separate days at least two days apart and within one month.
• Permanent residents in the study villages.
• Do not plan to emigrate in the next 2 years.

Exclusion Criteria

• Unable to provide consent.
• Treated for malignant tumor and life expectancy<2 years judged by study physician.
• Pregnancy, currently trying to become pregnant, or of child-bearing potential and not using birth control.
• Diagnosted psychiatric patients.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
a composite outcome of cardiovascular disease and all-cause mortality	up to 2-year

Secondary Outcome Measures

Name	Time	Method
Hospitalized or treated heart failure	up to 2-year
Change in mean systolic and diastolic blood pressure	up to 2-year
Fatal and non-fatal stroke	up to 2-year
Major cardiovascular diseases	up to 2-year
Fatal and non-fatal myocardial infarction	up to 2-year
Cardiovascular death	up to 2-year
Proportion of hypertension control	up to 2-year

Trial Locations

Locations (1)

First Hospital of China Medical University; 🇨🇳 Shenyang, Liaoning, China